Regan-Smith, S.; Fritzen, R.; Hierons, S.J.; Ajjan, R.A.; Blindauer, C.A.; Stewart, A.J.
Strategies for Therapeutic Amelioration of Aberrant Plasma Zn2+ Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects. Int. J. Mol. Sci. 2022, 23, 10302.
https://doi.org/10.3390/ijms231810302
AMA Style
Regan-Smith S, Fritzen R, Hierons SJ, Ajjan RA, Blindauer CA, Stewart AJ.
Strategies for Therapeutic Amelioration of Aberrant Plasma Zn2+ Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects. International Journal of Molecular Sciences. 2022; 23(18):10302.
https://doi.org/10.3390/ijms231810302
Chicago/Turabian Style
Regan-Smith, Spencer, Remi Fritzen, Stephen J. Hierons, Ramzi A. Ajjan, Claudia A. Blindauer, and Alan J. Stewart.
2022. "Strategies for Therapeutic Amelioration of Aberrant Plasma Zn2+ Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects" International Journal of Molecular Sciences 23, no. 18: 10302.
https://doi.org/10.3390/ijms231810302
APA Style
Regan-Smith, S., Fritzen, R., Hierons, S. J., Ajjan, R. A., Blindauer, C. A., & Stewart, A. J.
(2022). Strategies for Therapeutic Amelioration of Aberrant Plasma Zn2+ Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects. International Journal of Molecular Sciences, 23(18), 10302.
https://doi.org/10.3390/ijms231810302